TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies-Reference-Cited by-同舟云学术

TGFBR1*6A and Cancer: A Meta-Analysis of 12 Case-Control Studies

Published:2004-02-15 Issue:4 Volume:22 Page:756-758
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Pasche Boris¹,Kaklamani Virginia¹,Hou Nanjiang¹,Young Taya¹,Rademaker Alfred¹,Peterlongo Paolo²,Ellis Nathan²,Offit Kenneth²,Caldes Trinidad³,Reiss Michael⁴,Zheng Tongzhang⁵

Affiliation:

1. Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL

2. Memorial Sloan-Kettering Cancer Center, New York, NY

3. Hospital Clínico San Carlos, Martin Lagos, Madrid, Spain

4. Robert Wood Johnson Medical School, New Brunswick, NJ

5. Yale University School of Epidemiology and Public Health, New Haven, CT

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2004.99.271

Reference1 articles.

1. TGFBR1*6A and Cancer Risk: A Meta-Analysis of Seven Case-Control Studies

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects;npj Breast Cancer;2022-07-19

2. TGF-β Signaling in Liver, Pancreas, and Gastrointestinal Diseases and Cancer;Gastroenterology;2021-08

3. Polymorphisms in genes involved in breast cancer among Iranian patients;Personalized Medicine;2021-03

4. TGFβ biology in cancer progression and immunotherapy;Nature Reviews Clinical Oncology;2020-07-24

5. Association of TGF-β1 Polymorphisms with Breast Cancer Risk: A Meta-Analysis of Case–Control Studies;Cancers;2020-02-18